Early screening for psoriatic arthritis among psoriasis patients can help prevent irreversible joint damage, according to Adam Friedman, MD, whose message to dermatology clinicians centers on one blunt clinical reality: once structural joint destruction occurs, it does not reverse.

The headline claim is simple but consequential. Psoriasis patients under dermatologic care are routinely seen long before they ever reach a rheumatologist, which places the skin clinician in the pivotal position to catch inflammatory musculoskeletal symptoms at the stage when intervention can still change the disease trajectory.

Why does screening fall to dermatologists?

Friedman's argument rests on the structure of care delivery. Patients with plaque psoriasis see dermatologists regularly — often for years — before any joint complaint would prompt a separate rheumatology referral. That surveillance window is the opportunity.

Dermatology Times reported Friedman's position under the headline "Early Psoriatic Arthritis Screening Can Help Prevent Irreversible Damage, Friedman Says," framing the dermatology visit as the natural screening checkpoint for a condition that develops in a substantial share of psoriasis patients.

The clinical stakes define the urgency. Friedman emphasizes that irreversible damage is the endpoint clinicians are trying to avert. Delayed recognition allows inflammation to progress to structural joint destruction, and by the time that damage is visible, therapy can no longer restore what has been lost.

What should clinicians ask at every visit?

While the source does not specify a particular validated instrument, Friedman's core recommendation is that dermatologists screen proactively rather than wait for patients to volunteer joint complaints. In practice, that means dermatologists should:

• Ask psoriasis patients about joint pain, stiffness and swelling at routine visits
• Pay attention to morning stiffness and symptoms in the fingers, toes and lower back
• Refer suspected cases to rheumatology before structural damage appears
• Treat screening as a standing part of psoriasis management, not an afterthought

Patients frequently normalize aches and stiffness or attribute them to age or activity, so passive waiting for spontaneous reports reliably misses early disease. Active questioning is the mechanism by which the irreversible-damage endpoint gets avoided.

What does irreversible damage actually mean here?

The term anchors Friedman's warning. Psoriatic arthritis is a progressive inflammatory disease, and the damage it produces — joint erosion, deformity, functional loss — is permanent once established. That is precisely why the timing of diagnosis matters more in this disease than in many conditions dermatologists manage.

Skin and joints share inflammatory pathways in psoriatic disease, and the same patients dermatologists already manage for cutaneous symptoms carry the risk of musculoskeletal progression. The dermatology visit is therefore not incidental to rheumatologic outcomes; it is an early detection point that rheumatology cannot replicate on its own timeline.

Does early detection change outcomes?

Friedman's message, as reported, ties screening directly to damage prevention: identifying psoriatic arthritis early gives patients the chance to begin intervention before destruction occurs. The alternative — detection after joints are already compromised — limits treatment to managing symptoms and slowing further damage rather than preventing it.

This framing shifts the dermatologist's role from skin specialist to coordinator of whole-patient psoriatic disease care. It also implies a practical workflow change: joint symptom screening belongs in the standard psoriasis visit template, the same way clinicians already monitor for comorbidities.

The forward view

As Friedman's message circulates in dermatology circles, the practical takeaway for clinicians is to institutionalize the screening question in every psoriasis encounter — because the window to prevent irreversible joint damage closes quietly, one unscreened visit at a time.